Research and Development:
||West Nile Virus
||Supporting results in animal models
(5 repetitions, 3 virus strains)
||Successfully repeated animal experiments with two antigen sources
VacciGuard has signed an agreement with a large US vaccine company to support the proof-of-concept of one of the projects.
VacciGuard has successfully raised some funds from a private investor. VacciGuard is seeking an additional $2M to support the phase I/II clinical development of one of the projects.